Control of vertebrate development by MYC

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 9, 2013, Pages

  Hurlin, Peter J ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; MYC ASSOCIATED FACTOR X;

ANIMAL; CELL LINEAGE; CELL PROLIFERATION; CONGENITAL DISORDER; EMBRYO DEVELOPMENT; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; ONCOGENE MYC; PHYSIOLOGY; TRANSCRIPTION INITIATION; VERTEBRATE; REVIEW;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINEAGE; CELL PROLIFERATION; CONGENITAL ABNORMALITIES; EMBRYONIC DEVELOPMENT; GENES, MYC; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; VERTEBRATES;

EID: 84883759641     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a014332     Document Type: Article

References (147)

1. Adhikary S, Eilers M. 2005. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 6: 635-645.
2. Adhikary S, Peukert K, Karsunky H, Beuger V, Lutz W, El-sässer H-P, Möröy T, Eilers M. 2003. Mizl is required for early embryonic development during gastrulation. Mol Cell Biol 23: 7648-7657.
3. Arabi A, Wu S, Ridderstråle K, Bierhoff H, Shiue C, Fatyol K, Fahlén S, Hydbring P, Söderberg O, Grummt I, et al. 2005. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 7: 303-310.
4. Ayer DE, Kretzner L, Eisenman RN. 1993. Mad: A hetero-dimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72: 211-222.
5. Bettess MD, Dubois N, Murphy MJ, Dubey C, Roger C, Robine S, Trumpp A. 2005. c-Myc is required for the formation of intestinal crypts but dispensable for ho-meostasis of the adult intestinal epithelium. Mol Cell Biol 25: 7868-7878.
6. Blackwood EM, Eisenman RN. 1991. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science 251: 1211-1217.
7. Blackwood EM, Kretzner L, Eisenman RN. 1992. Myc and Max function as a nucleoprotein complex. Curr Opin Genet Dev 2: 227-235.
8. Bonal C, Thorel F, Ait-Lounis A, Reith W, Trumpp A, Her-rera PL. 2009. Pancreatic inactivation of c-Myc decreases acinar mass and transdifferentiates acinar cells into adi-pocytes in mice. Gastroenterology 136: 309-319.e9.
9. Burnichon N, Cascon A, Schiavi F, Morales NP, Comino-Méndez I, Abermil N, Inglada-Pérez L, De Cubas AA, Amar L, Barontini M, et al. 2012. MAX mutations cause hereditary and sporadic pheochromocytoma and para-ganglioma. Clin Cancer Res 18: 2828-2837.
10. Burns JC, Yoo JJ, Atala A, Jackson JD. 2012. MYC gene delivery to adult mouse utricles stimulates proliferation of postmitotic supporting cells in vitro. PLoS ONE 7: e48704.
11. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. 2005. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132: 885-896.
12. Cawley S, Bekiranov S, Ng HH, Kapranov P, Sekinger EA, Kampa D, Piccolboni A, Sementchenko V, Cheng J, Williams AJ, et al. 2004. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116: 499-509.
13. Celli J, Van Bokhoven H, Brunner HG. 2003. Feingold syndrome: Clinical review and genetic mapping. Am J Med Genet A 122A: 294-300.
14. Chandriani S, Frengen E, Cowling VH, Pendergrass SA, Perou CM, Whitfield ML, Cole MD. 2009. A core MYC gene expression signature is prominent in basal-like breast cancer but only partially overlaps the core serum response. PLoS ONE 4: e6693.
15. Charron J, Malynn BA, Fisher P, Stewart V, Jeannotte L, Goff SP, Robertson EJ, Alt FW. 1992. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev 6: 2248-2257.
16. Clevers H, Nusse R. 2012. Wnt/β-catenin signaling and disease. Cell 149: 1192-1205.
17. Cognet M, Nougayrede A, Malan V, Callier P, Cretolle C, Faivre L, Genevieve D, Goldenberg A, Heron D, Mercier S, et al. 2011. Dissection of the MYCN locus in Feingold syndrome and isolated oesophageal atresia. Eur J Hum Genet 19: 602-606.
18. Comino-Méndez I, Gracia-Aznårez FJ, Schiavi F, Landa I, Leandro-Garcia LJ, Leton R, Honrado E, Ramos-Medina R, Caronia D, Pita G, et al. 2011. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 43: 663-667.
19. Conacci-Sorrell M, Eisenman RN. 2011. Post-translational control of Myc function during differentiation. Cell Cycle 10: 604-610.
20. Conacci-Sorrell M, Ngouenet C, Eisenman RN. 2010. Myc-nick: A cytoplasmic cleavage product of Myc that promotes a-tubulin acetylation and cell differentiation. Cell 142: 480-493.
21. Couillard M, Trudel M. 2009. C-tnyc as a modulator of renal stem/progenitor cell population. DevDyn 238:405-414.
22. Cowling VH, Cole MD. 2006. Mechanism of transcriptional activation by the Myc oncoproteins. Setnin Cancer Biol 16: 242-252.
23. Cowling VH, Cole MD. 2007. The Myc transactivation domain promotes global phosphorylation of the RNA po-lymerase II carboxy-terminal domain independently of direct DNA binding. Mol Cell Biol 27: 2059-2073.
24. Cowling VH, Cole MD. 2010. Myc regulation of mRNA cap methylation. Genes Cancer 1: 576-579.
25. Dang CV 2012. MYC on the path to cancer. Cell 149:22-35.
26. Davis AC, Wims M, Spotts CD, Hann SR, Bradley A. 1993. A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 7: 671-682.
27. de Jong EM, Felix JF, De Klein A, Tibboel D. 2010. Etiology of esophageal atresia and tracheoesophageal fistula: Mind the gap. Curr Gastroenterol Rep 12: 215-222.
28. de la Cova C, Abril M, Bellosta P, Gallant P, Johnston LA. 2004. Drosophila myc regulates organ size by inducing cell competition. Cell 117: 107-116.
29. Delgado MD, Leon J. 2010. Myc roles in hematopoiesis and leukemia. Genes Cancer 1: 605-616.
30. de Pontual L, Yao E, Callier P, Faivre L, Drouin V, Cariou S, Van Haeringen A, Geneviéve D, Goldenberg A, Oufadem M, et al. 2011. Germline deletion of the miR-17 ~ 92 cluster causes skeletal and growth defects in humans. Nat Genet 43: 1026-1030.
31. Dominguez-Frutos E, Lopez-Hernandez I, Vendrell V, Neves J, Gallozzi M, Gutsche K, Quintana L, Sharpe J, Knoepfler PS, Eisenman RN, et al. 2011. N-myc controls proliferation, morphogenesis, and patterning of the inner ear. J Neurosci 31: 7178-7189.
32. Dominguez-Sola D, Ying CY, Grandori C, Ruggiero L, Chen B, Li M, Galloway DA, Gu W, Gautier J, Dalla-Favera R. 2007. Non-transcriptional control of DNA replication by c-Myc. Nature 448: 445-451.
33. Dong J, Sutor S, Jiang G, Cao Y, Asmann YW, Wigle DA. 2011. c-Myc regulates self-renewal in bronchoalveolar stem cells. PLoS ONE 6: e23707.
34. Downs KM, Martin GR, Bishop JM. 1989. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev 3: 860-869.
35. Dubois NC, Adolphe C, Ehninger A, Wang RA, Robertson EJ, Trumpp A. 2008. Placental rescue reveals a sole requirement for c-Myc in embryonic erythroblast survival and hematopoietic stem cell function. Development 135: 2455-2465.
36. Eberhardy SR, Farnham PJ,. 2001.c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism.Biol Chem 276: 48562-48571.
37. Eilers M, Eisenman RN. 2008. Myc's broad reach. Genes Dev 22: 2755-2766.
38. Fay A, Misulovin Z, Li J, Schaaf CA, Gause M, Gilmour DS, Dorsett D. 2011. Cohesin selectively binds and regulates genes with paused RNA polymerase. CurrBiolU: 1624-1634.
39. Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B. 2003. Genomic targets of the human c-Myc protein. Genes Dev 17: 1115-1129.
40. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. 2001. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 15: 2069-2082.
41. Gallant P, Steiger D. 2009. Myc's secret life without Max. Cell Cycle 8: 3848-3853.
42. Gandarillas A, Watt FM. 1997. c-Myc promotes differentiation of human epidermal stem cells. Genes Dev 11:2869-2882.
43. Gandarillas A, Davies D, Blanchard JM. 2000. Normal and c-Myc-promoted human keratinocyte differentiation both occur via a novel cell cycle involving cellular growth and endoreplication. Oncogene 19: 3278-3289.
44. Gerondakis S, Siebenlist U. 2010. Roles of the NF-kB pathway in lymphocyte development and function. Cold Spring Harb Perspect Biol 2: a000182.
45. Gomez-Roman N, Grandori C, Eisenman RN, White RJ. 2003. Direct activation of RNA polymerase III transcription by c-Myc. Nature 421: 290-294.
46. Grady EF, Schwab M, Rosenau W. 1987. Expression of N-myc and c-src during the development of fetal human brain. Cancer Res 47: 2931-2936.
47. Grandori C, Cowley SM, James LP, Eisenman RN. 2000. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16: 653-699.
48. Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngoue-net C, Galloway DA, Eisenman RN, White RJ. 2005. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat CellBioll: 311-318.
49. Grewal SS, Li L, Orian A, Eisenman RN, Edgar BA. 2005. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nat Cell Biol 7: 295-302.
50. Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall Olio V, Zardo G, Nervi C, Bernard L, Amati B. 2006. Myc-binding-site recognition in the human genome is determined by chromatin context. Nat Cell Biol 8: 764-770.
51. Habib T, Park H, Tsang M, De Alborån IM, Nicks A, Wilson L, Knoepfler PS, Andrews S, Rawlings DJ, Eisenman RN, et al. 2007. Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. JCell Biol 179:717-731.
52. Harmelink CM, Jiao K. 2010. Critical functions of myocar-dial Mycn in the developing mouse heart. Dev Biol 356: 153.
53. Harmelink C, Peng Y, DeBenedittis P, Chen H, Shou W, Jiao K. 2013. Myocardial Mycn is essential for mouse ventricular wall morphogenesis. Dev Biol 373: 53-63.
54. Hatton KS, Mahon K, Chin L, Chiu FC, Lee HW, Peng D, Morgenbesser SD, Horner J, DePinho RA. 1996. Expression and activity of L-Myc in normal mouse development. Mol Cell Biol 16: 1794-1804.
55. He C, Hu H, Braren R, Fong S-Y, Trumpp A, Carlson TR, Wang RA. 2008. c-myc in the hematopoietic lineage is critical for its angiogenic function in the mouse embryo. Development 135: 2467-2477.
56. He S, Liu Z, Oh D-Y, Thiele CJ. 2013. MYCN and the epi-genome. Front Oncol 3: 1.
57. Herkert B, Eilers M. 2010. Transcriptional repression: The dark side of myc. Genes Cancer 1: 580-586.
58. Hirvonen H, Mäkelä TP, Sandberg M, Kalimo H, Vuorio E, Alitalo K. 1990. Expression of the myc proto-oncogenes in developing human fetal brain. Oncogene 5: 1787-1797.
59. Hopewell R, Ziff EB. 1995. The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max. Mol Cell Biol 15: 3470-3478.
60. Horsfield JA, Print CG, Mönnich M. 2012. Diverse developmental disorders from the one ring: Distinct molecular pathways underlie the cohesinopathies. Front Genet 3: 171.
61. Hu MC, Rosenblum, ND, 2005. Smadl, β-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development, 132: 215-225.
62. Hurlin PJ, Huang J. 2006. The MAX-interacting transcription factor network. Semin Cancer Biol 16: 265-274.
63. Hurlin PJ, Queva C, Eisenman RN. 1997. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Devil: 44-58.
64. Hurlin PJ, Steingrimsson E, Copeland NG, Jenkins NA, Eisenman RN. 1999. Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO J 18: 7019-7028.
65. Hurlin PJ, Zhou Z-Q, Toyo-oka K, Ota S, Walker WL, Hirotsune S, Wynshaw-Boris A. 2003. Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J 22: 4584-4596.
66. Jackson T, Allard MF, Sreenan CM, Doss LK, Bishop SP, Swain JL. 1990. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 10: 3709-3716.
67. Jaffredo T, Vandenbunder B, Dieterlen-Liévre E 1989. In situ study of c-myc protein expression during avian development. Development 105: 679-695.
68. Ji H, Wu G, Zhan X, Nolan A, Koh C, De Marzo A, Doan HM, Fan J, Cheadle C, Fallahi M, et al. 2011. Cell-type independent MYC target genes reveal a primordial signature involved in biomass accumulation. PLoS ONE 6: e26057.
69. Kato K, Kanamori A, Wakamatsu Y, Sawai S, Kondoh H. 1991. Tissue distribution of N-myc expression in the early organogenesis period of the mouse embryo. Dev Growth Differ 33: 29-39.
70. Kidder BL, Yang J, Palmer S. 2008. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS ONE 3: e3932.
71. King MW, Roberts JM, Eisenman RN. 1986. Expression of the c-myc proto-oncogene during development oiXen-opus laevis. Mol Cell Biol 6: 4499-4508.
72. Knoepfler PS, Kenney AM. 2006. Neural precursor cycling at sonic speed: N-Myc pedals, GSK-3 brakes. Cell Cycle 5: 47-52.
73. Knoepfler PS, Cheng PF, Eisenman RN. 2002. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neu-ronal differentiation. Genes Dev 16: 2699-2712.
74. Knoepfler PS, Zhang X, Cheng PF, Gafken PR, McMahon SB, Eisenman RN. 2006. Myc influences global chroma-tin structure. EMBO J 25: 2723-2734.
75. Kopecky BJ, Decook R, Fritzsch B. 2012. N-Myc and L-Myc are essential for hair cell formation but not maintenance. Brain Res 1484: 1-14.
76. Kuwahara A, Hirabayashi Y, Knoepfler PS, Taketo MM, Sa-kai J, Kodama T, Gotoh Y 2010. Wnt signaling and its downstream target N-myc regulate basal progenitors in the developing neocortex. Development 137:1035-1044.
77. Laurenti E, Varnum-Finney B, Wilson A, Ferrero I, Blanco-Bose WE, Ehninger A, Knoepfler PS, Cheng P-F, Mac-Donald HR, Eisenman RN, et al. 2008. Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. Cell Stem Cell 3: 611-624.
78. Laurenti E, Wilson A, Trumpp A. 2009. Myc's other life: Stem cells and beyond. Curr Opin Cell Biol 21: 844-854.
79. Lawlor ER, Soucek L, Brown-Swigart L, Shchors K, Bialucha CU, Evan GI. 2006. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis. Cancer Res 66: 4591-4601.
80. Lee H, Casadesus G, Nunomura A, Zhu X, Castellani RJ, Richardson SL, Perry G, Felsher DW, Petersen RB, Smith MA. 2009. The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse. AmJPathol 174: 891-897.
81. Lee B-K, Bhinge AA, Battenhouse A, McDaniell RM, Liu Z, Song L, Ni Y, Birney E, Lieb JD, Furey TS, et al. 2012. Cell-type specific and combinatorial usage of diverse transcription factors revealed by genome-wide binding studies in multiple human cells. Genome Res 22: 9-24.
82. Li X, Ohgi KA, Zhang J, Krones A, Bush KT, Glass CK, Nigam SK, Aggarwal AK, Maas R, Rose DW, et al. 2003a. Eya protein phosphatase activity regulates Sixl-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 426: 247-254.
83. Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B. 2003b. A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells. Proc Natl Acad Sci 100: 8164-8169.
84. Lin C-H, Lin C, Tanaka H, Fero ML, Eisenman RN. 2009. Gene regulation and epigenetic remodeling in murine embryonic stem cells by c-Myc. PLoS ONE 4: e7839.
85. Lin CY, Lovén J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. 2012. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151: 56-67.
86. Link JM, Ota S, Zhou Z-Q, Daniel CJ, Sears RC, Hurlin PJ. 2012. A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis. Proc Natl Acad Sci 109: 19685-19690.
87. Littlewood TD, Kreuzaler P, Evan GI. 2012. All things to all people. Cell 151: 11-13.
88. Malynn BA, De Alboran IM, O'Hagan RC, Bronson R, Davidson L, DePinho RA, Alt FW. 2000. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 14: 1390-1399.
89. Martinato F, Cesaroni M, Amati B, Guccione E. 2008. Analysis of Myc-induced histone modifications on target chromatin. PLoS ONE 3: e3650.
90. Misulovin Z, Schwartz YB, Li X-Y, Kahn TG, Cause M, MacArthur S, Fay JC, Eisen MB, Pirrotta V, Biggin MD, et al. 2008. Association of cohesin and Nipped-B with transcriptionally active regions of the Drosophila mela-nogaster genome. Chromosoma 117: 89-102.
91. Moens CB, Auerbach AB, Conlon RA, Joyner AL, Rossant J. 1992. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev 6: 691-704.
92. Moens CB, Stanton BR, Parada LF, Rossant J. 1993. Defects in heart and lung development in compound heterozy-gotes for two different targeted mutations at the N-myc locus. Development 119: 485-499.
93. Moreno E, Basler K. 2004. dMyc transforms cells into super-competitors. Cell 117: 117-129.
94. Moumen M, Chiche A, Deugnier M-A, Petit V, Gandarillas A, Glukhova MA, Faraldo MM. 2012. The proto-onco-gene Myc is essential for mammary stem cell function. Stem Cells 30: 1246-1254.
95. Mousavi K, Sartorelli V. 2010. Myc-nick: The force behind c-Myc. Sci Signal 3: e49.
96. Mugrauer G, Alt FW, Ekblom P. 1988. N-myc proto-onco-gene expression during organogenesis in the developing mouse as revealed by in situ hybridization. J Cell Biol 107: 1325-1335.
97. Muncan V, Sansom OJ, Tertoolen L, Phesse TJ, Begthel H, Sancho E, Cole AM, Gregorieff A, De Alboran IM, Clev-ers H, et al. 2006. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc. Mol Cell Biol 26: 8418-8426.
98. Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA, Brown-Swigart L, Johnson L, Evan GI. 2008. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14: 447-457.
99. Nagy A, Moens C, Ivanyi E, Pawling J, Gertsenstein M, Hadjantonakis A-K, Pirity M, Rossant J. 1998. Dissecting the role of N-myc in development using a single targeting vector to generate a series of alleles. CurrBiolS: 661-666.
100. Nakhai H, Siveke JT, Mendoza-Torres L, Schmid RM. 2008. Conditional inactivation of Myc impairs development of the exocrine pancreas. Development 135: 3191-3196.
101. Nature Medicine Commentaries. 2013. Unlocking the mysterious mechanisms of MYC. NatMed 19: 26-27.
102. Nesbit CE, Tersak JM, Prochownik EV 1999. MYC onco-genes and human neoplastic disease. Oncogene 18:3004-3016.
103. Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, et al. 2012. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151: 68-79.
104. Okubo T, Knoepfler PS, Eisenman RN, Hogan BLM. 2005. Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development 132: 1363-1374.
105. Orian A, Van Steensel B, Delrow J, Bussemaker HJ, Li L, Sawado T, Williams E, Loo LWM, Cowley SM, Yost C, et al. 2003. Genomic binding by the Drosophila Myc, Max, Mad/Mnt transcription factor network. Genes Dev 17: 1101-1114.
106. Oskarsson T, Essers MAG, Dubois N, Offner S, Dubey C, Roger C, Metzger D, Chambon P, Hummler E, Beard P, et al. 2006. Skin epidermis lacking the c-myc gene is resistant to Ras-driven tumorigenesis but can reacquire sensitivity upon additional loss of the p21Cipl gene. Genes Dev 20: 2024-2029.
107. Ota S, Zhou Z-Q, Keene DR, Knoepfler P, Hurlin PJ. 2007. Activities of N-Myc in the developing limb link control of skeletal size with digit separation. Development 134: 1583-1592.
108. Partanen JI, Nieminen Al, Mäkelä TP, Klefstrom J. 2007. Suppression of oncogenic properties of c-Myc by LKB1-controlled epithelial organization. Proc Natl Acad Sci 104: 14694-14699.
109. Patel JH, Loboda AP, Showe MK, Showe LC, McMahon SB. 2004. Analysis of genomic targets reveals complex func tions of MYC. Nat Rev Cancer 4: 562-568.
110. Pelengaris S, Littlewood T, Khan M, Elia G, Evan G. 1999. Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell 3: 565-577.
111. Pello OM, Pizzol MD, Mirolo M, Soucek L, Zammataro L, Amabile A, Doni A, Nebuloni M, Swigart LB, Evan GI, et al. 2012. Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology. Blood 119: 411-421.
112. Pfeifer-Ohlsson S, Rydnert J, Goustin AS, Larsson E, Bet-sholtz C, Ohlsson R. 1985. Cell-type-specific pattern of myc protooncogene expression in developing human embryos. Proc Natl Acad Sci 82: 5050-5054.
113. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA. 2010. c-Myc regulates transcrip-tional pause release. Cell 141: 432-445.
114. Ribon V, Leff T, Saltiel AR. 1994. c-Myc does not require max for transcriptional activity in PC-12 cells. Mol Cell Neuro-sci 5: 277-282.
115. Sala V, Gallo S, Leo C, Gatti S, Gelb BD, Crepaldi T 2012. Signaling to cardiac hypertrophy: Insights from human and mouse RASopathies. Mol Med 18: 938-947.
116. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. 2007. Myc deletion rescues Ape deficiency in the small intestine. Nature 446: 676-679.
117. Sawai S, Shimono A, Wakamatsu Y, Palmes C, Hanaoka K, Kondoh H. 1993. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 117: 1445-1455.
118. Schmid P, Schulz WA, Hameister H. 1989. Dynamic expression pattern of the myc protooncogene in midgestation mouse embryos. Science 243: 226-229.
119. Sears RC. 2004. The life cycle of C-myc: From synthesis to degradation. Cell Cycle 3: 1133-1137.
120. Sharma VM, Draheim KM, Kelliher MA. 2007. The Notch 1/c-Myc pathway in T cell leukemia. Cell Cycle 6: 927-930.
121. Shaw-Smith C. 2006. Oesophageal atresia, tracheo-oeso-phageal fistula, and the VACTERL association: Review of genetics and epidemiology. J Med Genet 43: 545-554.
122. Shen-Li H, O'Hagan RC, Hou H, Homer JW, Lee H-W, DePinho RA. 2000. Essential role for Max in early embryonic growth and development. Genes Dev 14: 17-22.
123. Shu W, Guttentag S, Wang Z, Andl T, Ballard P, Lu MM, Piccolo S, Birchmeier W, Whitsett JA, Millar SE, et al. 2005. Wnt/β-catenin signaling acts upstream of N-myc, BMP4, and FGF signaling to regulate proximal-dis tal patterning in the lung. Dev Biol 283: 226-239.
124. Shung C-Y, Ota S, Zhou Z-Q, Keene DR, Hurlin PJ. 2012. Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II. Hum Mol Genet 21: 4628-4644.
125. Slamon DJ, Cline MJ. 1984. Expression of cellular oncogenes during embryonic and fetal development of the mouse. Proc Natl Acad Sci 81: 7141-7145.
126. Soufi A, Donahue G, Zaret KS. 2012. Facilitators and impediments of the pluripotency reprogramming factors' initial engagement with the genome. Cell 151:994-1004.
127. Srivastava S, Mishra RK, Dhawan J. 2010. Regulation of cellular chromatin state. Organogenesis 6: 37-47.
128. Stanton BR, Perkins AS, Tessarollo L, Sassoon DA, Parada LF. 1992. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev 6: 2235-2247.
129. Steiger D, Furrer M, Schwinkendorf D, Gallant P. 2008. Max-independent functions of Myc in Drosophila mela-nogaster. Nat Genet 40: 1084-1091.
130. Stoelzle T, Schwarb P, Trumpp A, Hynes NE. 2009. c-Myc affects mRNA translation, cell proliferation and progenitor cell function in the mammary gland. BMC Biol 7:63.
131. Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by denned factors. Cell 126: 663-676.
132. Ten Berge D, Brugmann SA, Helms JA, Nusse R. 2008. Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development. Development 135: 3247-3257.
133. Torres R, Schreiber-Agus N, Morgenbesser SD, DePinho RA. 1992. Myc and Max: A putative transcriptional complex in search of a cellular target. Curr Opin Cell Biol 4: 468-474.
134. Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR, Bishop JM. 2001. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414: 768-773.
135. van Bokhoven H, Celli J, Van Reeuwijk J, Rinne T, Glaude-mans B, Van Beusekom E, Rieu P, Newbury-Ecob RA, Chiang C, Brunner HG. 2005. MYCN haploinsufficiency is associated with reduced brain size and intestinal atre-sias in Feingold syndrome. Nat Genet 37: 465-467.
136. Varlakhanova N, Cotterman R, Bradnam K, Korf I, Knoep-fler PS. 2011. Myc and Miz-1 have coordinate genomic functions including targeting Hox genes in human embryonic stem cells. Epigenetics Chromatin 4: 20.
137. Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR. 2001. Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet 28: 165-168.
138. Wakamatsu Y, Watanabe Y, Shimono A, Kondoh H. 1993. Transition of localization of the N-Myc protein from nucleus to cytoplasm in differentiating neurons. Neuron 10: 1-9.
139. Wartiovaara K, Barnabe-Heider F, Miller FD, Kaplan DR. 2002. N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons. J Neurosci 22: 815-824.
140. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. 2007. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448: 318-324.
141. Wilson A, Murphy MJ, Oskarsson T, Kaloulis K, Bettess MD, Oser GM, Pasche A-C, Knabenhans C, Macdonald HR, Trumpp A. 2004. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 18: 2747-2763.
142. Xiao G, Mao S, Baumgarten G, Serrano J, Jordan MC, Roos KP, Fishbein MC, MacLellan WR. 2001. Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. CircRes 89: 1122-1129.
143. Zanet J, Pibre S, Jacquet C, Ramirez A, de Alborån IM, Gandarillas A. 2005. Endogenous Myc controls mammalian epidermal cell size, hyperproliferation, endoreplica-tion and stem cell amplification. J Cell Sci 118: 1693-1704.
144. Zeller KI, Zhao X, Lee CWH, Chiu KP, Yao F, Yustein JT, Ooi HS, Orlov YL, Shahab A, Yong HC, et al. 2006. Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci 103: 17834-17839.
145. Zervos AS, Gyuris J, Brent R. 1993. Mxil, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72: 223-232.
146. Zhou Z-Q, Shung C-Y, Ota S, Akiyama H, Keene DR, Hurlin PJ. 2011. Sequential and coordinated actions of c-Myc and N-Myc control appendicular skeletal development. PLoS ONE 6: el8795.
147. Zimmerman KA, Yancopoulos GD, Collum RG, Smith RK, Kohl NE, Denis KA, Nau MM, Witte ON, Toran-Allerand D, Gee CE. 1986. Differential expression of myc family genes during murine development. Nature 319: 780-783.